Serina Therapeutics SER
NYSE SER
$2.43 -0.14 (-5.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Serina Therapeutics (SER) Gross Margin (QoQ) (2018 - 2023)

Analysis

Serina Therapeutics (SER) Gross Margin (QoQ) (2018 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Serina Therapeutics 40.47 Mn 17.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -11,546.00
Sep 30, 2023 6,010.00
Jun 30, 2023 2,714.00
Mar 31, 2023 -5,750.00
Dec 31, 2022 4,306.00
Sep 30, 2022 -556.00
Jun 30, 2022 -3,000.00
Sep 30, 2021 2,680.00
Jun 30, 2021 -2,978.00
Mar 31, 2021 -219.00
Dec 31, 2020 2,147.00
Sep 30, 2020 -1,797.00
Jun 30, 2020 -554.00
Mar 31, 2020 1,327.00
Dec 31, 2019 -247.00
Sep 30, 2019 203.00
Jun 30, 2019 229.00
Mar 31, 2019 2,465.00
Dec 31, 2018 -4,194.00
Sep 30, 2018 1,808.00